Prestige Consumer Healthcare
PBH
$64.65
Share price
-0.51%
Change (1 day)
9.15%
Change (1 year)
Categories
Prestige Consumer Healthcare (PBH) - Net assets
Net assets on the balance sheet as of December 2023 : $1.60 B
According to Prestige Consumer Healthcare's latest financial reports the company has $1.60 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Prestige Consumer Healthcare - Net assets on balance sheet (from 2004 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-03-31 | $1.44 B | -8.27% |
| 2022-03-31 | $1.57 B | 16.15% |
| 2021-03-31 | $1.35 B | 16% |
| 2020-03-31 | $1.17 B | 6.86% |
| 2019-03-31 | $1.09 B | -7.02% |
| 2018-03-31 | $1.17 B | 43.29% |
| 2017-03-31 | $0.82 B | 10.51% |
| 2016-03-31 | $0.74 B | 18.6% |
| 2015-03-31 | $0.62 B | 11.41% |
| 2014-03-31 | $0.56 B | 17.87% |
| 2013-03-31 | $0.47 B | 18.68% |
| 2012-03-31 | $0.40 B | 11.3% |
| 2011-03-31 | $0.36 B | 9.96% |
| 2010-03-31 | $0.32 B | 11.78% |
| 2009-03-31 | $0.29 B | -38.55% |
| 2008-03-31 | $0.47 B | 7.58% |
| 2007-03-31 | $0.44 B | 8.78% |
| 2006-03-31 | $0.40 B | 7.16% |
| 2005-03-31 | $0.38 B | 201.99% |
| 2004-03-31 | $0.12 B | 188.45% |
| 2003-03-31 | $43.85 M | -25.33% |
| 2002-03-31 | $58.73 M | 27.61% |
| 2001-03-31 | $46.03 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $70.02 B | 4,274.66% | 🇺🇸 USA |
 Procter & Gamble PG | $50.33 B | 3,044.67% | 🇺🇸 USA |
 Novartis NVS | $39.75 B | 2,383.85% | 🇨🇭 Switzerland |
 Pfizer PFE | $89.28 B | 5,478.48% | 🇺🇸 USA |
 Abbott Laboratories ABT | $38.82 B | 2,325.81% | 🇺🇸 USA |
 Clorox CLX | $0.25 B | -84.07% | 🇺🇸 USA |
 CVS Health CVS | $74.15 B | 4,532.70% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $16.71 B | 944.48% | 🇬🇧 UK |
 Rite Aid
RAD | -$1.97 B | -222.85% | 🇺🇸 USA |
 Taro Pharmaceutical TARO | $1.77 B | 11.15% | 🇮🇱 Israel |